Skip to main content

Table 4 Relative excess risk of death of prostate cancer patients based on Gleason score and PSA categories

From: The modified Glasgow prognostic score in prostate cancer: results from a retrospective clinical series of 744 patients

  Modified Glasgow prognostic score P-value for trend
  0 1 2  
Gleason score-specific analysis     
Gleason < 7     
   Relative excess risk (95% CI)a reference 1.66 (0.15-18.65) 46.04 (4.59-461.70) 0.013
   Relative excess risk (95% CI)b reference 3.26 (0.67-15.89) 20.46 (3.43-121.97) 0.002
Gleason = 7     
   Relative excess risk (95% CI)a reference 3.06 (1.28-7.35) 2.19 (0.25-19.20) 0.021
   Relative excess risk (95% CI)b reference 3.99 (1.78-8.97) 2.25 (0.31-16.08) 0.003
Gleason 8-10     
   Relative excess risk (95% CI)a reference 2.09 (1.29-3.37) 5.27 (2.73-10.22) <0.001
   Relative excess risk (95% CI)b reference 2.04 (1.30-3.22) 5.64 (3.00-10.59) <0.001
Unknown Gleason     
   Relative excess risk (95% CI)a reference 1.55 (0.98-2.46) 2.18 (1.13-4.22) 0.015
   Relative excess risk (95% CI)b reference 1.51 (0.96-2.37) 1.88 (0.98-3.61) 0.035
PSA-specific analysis     
PSA < 10ug/l     
   Relative excess risk (95% CI)a reference 3.43 (1.37-8.59) 8.29 (2.76-24.87) <0.001
   Relative excess risk (95% CI)b reference 3.86 (1.48-10.03) 9.65 (3.13-29.75) <0.001
PSA 10-20ug/l     
   Relative excess risk (95% CI)a reference 1.87 (0.63-5.58) 3.65 (0.47-28.49) 0.163
   Relative excess risk (95% CI)b reference 2.54 (0.90-7.18) 2.50 (0.20-31.07) 0.088
PSA > 20ug/l     
   Relative excess risk (95% CI)a reference 2.20 (1.50-3.24) 5.08 (3.03-8.55) <0.001
   Relative excess risk (95% CI)b reference 2.25 (1.57-3.20) 5.01 (3.05-8.22) <0.001
  1. All estimates were presented after adjusted for age, deprivation and inpatient bed days. a = five-year relative survival, b = 10-year relative survival.